Clinical Trial Update: Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating various sunitinib schedules in kidney cancer (renal cell carcinoma), status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Neoplasms
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Kidney Neoplasms, Metastatic Renal Cell Cancer | Phase 2 | Status: UNKNOWN